Theravance

TBPH · NASDAQ🇺🇸

Overview

Earnings Dividends Seasonality Metrics

Reported earnings 8 days ago

Total Revenue

$20M

Previous year: $16.9M

+18.5%

EPS

$0.07

Previous year: -$0.06

-216.7%

YUPELRI U.S. Net Sales

$71.4M

Previous year: $62.2M

+14.8%

YUPELRI Demand Growth

6%

YUPELRI Hospital Doses Growth

Loading...

Theravance

Unlock previous datapoints

Upgrade

Theravance

Unlock previous datapoints

Upgrade

Theravance Revenue by Segment

Theravance Revenue by Geographic Location

Revenue by Segment

YUPELRI Revenue

CapyFin.com

Revenue by Geographic Location

United States Revenue

CapyFin.com

Historical Earnings Impact

Analyze how earnings announcements historically affect stock price performance

Avg. Return Before/After Earnings

Loading earnings performance data...

Loading earnings reaction data...

Key Statistics

Market Cap

$782M

P/E Ratio

-25.73

Sector

N/A

Industry

N/A

52-Week High

$20.7

52-Week Low

$8.3

YUPELRI U.S. Net Sales

$71.4M

YUPELRI Demand Growth

6%

YUPELRI Hospital Doses Growth

29%

TRELEGY Global Net Sales

$1B

Products

Get in Touch

Resources

Theravance

Theravance

Theravance

Theravance Revenue by Segment

Theravance Revenue by Geographic Location

Revenue by Segment

YUPELRI Revenue

Revenue by Geographic Location

United States Revenue

Historical Earnings Impact

Avg. Return Before/After Earnings

Key Statistics